0.1% sodium hyaluronate ophthalmic solution

DRUG2 trials

Sponsors

Alcon Research, Santen Pharmaceutical Co., Ltd.

Conditions

Dry EyeDry Eye Disease

Phase 2

Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time

CompletedNCT00760045

Alcon ResearchDry Eye Disease

Start: 2008-08-31Target: 40Updated: 2010-01-06

Phase 3

Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

CompletedNCT01240382

Santen Pharmaceutical Co., Ltd.Dry Eye

Updated: 2014-08-13